Data / Form D filings / Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc.: Form D filings
Luminary Therapeutics, Inc., a biotechnology company in Minneapolis, MN, filed 8 Form D notices with the SEC between 2019 and 2025. The latest, on November 5, 2025, reports $1.4 million sold of a $12.4 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1200 Washington Avenue South, Suite 260, Minneapolis, MN, 55415
- Phone
- (612) 309-7653
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1793860
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | New notice | $12,388,157 | $1,406,112 | $10,982,045 | 6 | Oct 14, 2025 | sec.gov |
| Jan 8, 2025 | New notice | $5,920,000 | $5,184,500 | $735,500 | 48 | Nov 20, 2024 | sec.gov |
| Jan 8, 2025 | Amendment | $5,500,000 | $5,222,095 | $277,905 | 49 | Sep 28, 2022 | sec.gov |
| Aug 3, 2023 | Amendment | $3,500,000 | $2,379,500 | $1,120,500 | 12 | Sep 28, 2022 | sec.gov |
| Jan 11, 2023 | New notice | $2,750,000 | $2,154,500 | $595,500 | 10 | Sep 28, 2022 | sec.gov |
| Nov 4, 2021 | New notice | $1,500,000 | $374,993 | $1,125,007 | 3 | Oct 26, 2021 | sec.gov |
| Feb 9, 2021 | New notice | $1,000,000 | $825,000 | $175,000 | 11 | Jan 12, 2021 | sec.gov |
| Nov 14, 2019 | New notice | $1,490,000 | $1,490,000 | 11 | Oct 29, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Branden Moriarity | Director | |
| Mark Chance | Director | |
| Tracey Lodie | Director | |
| James Haymaker | Director, Promoter | |
| John Wells | Director | |
| Jeff Ross | Director | |
| Jeff Liter | Executive Officer, Director, Promoter |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Luminary Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.